Clinical trials
Elderly clinical trials
Below are recruiting elderly clinical trials, each written for real people, not researchers. We’re tracking 526 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05555693Recruiting
Brain chemistry study after surgery in older adults
This study looks at how brain “metabolomics” (small chemical signals in the brain/body) relate to thinking or mood problems that can happen after surgery in people age 65 and older. It may help doctors understand who is more likely to have these side effects after an operation.
Shanghai, Shanghai MunicipalityAges 65 years+ - NCT05557552Recruiting
Chemo and immunotherapy plus chest radiation for stage III lung cancer
This trial studies a treatment plan that combines chemotherapy, immunotherapy, and radiation to the chest for people with unresectable stage III non-small-cell lung cancer (NSCLC). It may help by delivering anti-cancer drugs while also shrinking tumors with targeted radiation, especially for people who are not able to have the standard “chemo and radiation at the same time.”
Shanghai, Shanghai MunicipalityAges 18–80 - NCT05572229RecruitingPhase 2
Teclistamab treatment for older adults with multiple myeloma
This Phase 2 trial studies how well teclistamab works when used in combination for people age 65 and older with multiple myeloma. It aims to see whether this treatment can control the cancer safely in older patients who may not do high-dose chemotherapy or stem cell transplant.
AmiensAges 65 years+ - NCT05580861RecruitingPhase 1/Phase 2
Sulfasalazine for newly diagnosed AML in older adults on chemo
This Phase 1/2 trial studies whether sulfasalazine, added to intensive chemotherapy, can help older adults with newly diagnosed acute myeloid leukemia (AML). It aims to improve treatment effectiveness and track leukemia “leftover cells” in some participants.
AmiensAges 60 years+ - NCT05603884RecruitingPhase 2
New treatment plan for older adults with newly diagnosed AML
This trial studies a two-part chemotherapy plan for older adults newly diagnosed with acute myeloid leukemia (AML) who can’t take the usual standard induction treatment. It aims to improve how well treatment works while taking into account age and other health conditions.
Xiamen, FujianAges 60 years+ - NCT05679661Recruiting
Immunity-focused nutrition before surgery to reduce lung infections
This study gives an immunity-supporting nutrition plan and an oral cleaning product before and around surgery to help older adults avoid breathing-related complications. It is mainly for people at higher risk of post-surgery lung problems, and it checks whether the approach is safe and helpful.
BeijingAges 65 years+ - NCT05681585Recruiting
Advance care planning for very frail older adults at home
This study looks at advance care planning (talking ahead about care goals and preferences) for very frail people who are living at home after a hospital admission. It includes both the patient and a close relative, and may help improve how future care decisions are discussed.
Oslo, Bærum kommuneAges 70 years+ - NCT05710809Recruiting
Exercise and health check study for older colorectal cancer patients
This trial looks at sarcopenia (loss of muscle strength/size) and vertigo (feeling dizzy or off-balance) in older adults with colorectal cancer. It tests whether a structured, exercise-based approach can help these issues alongside cancer care.
CopenhagenAges 65 years+ - NCT05741593Recruiting
Interview study for older adults after ischemic stroke
This study talks with people age 65+ who were hospitalized for an ischemic stroke and are already on blood-thinning medicines to learn about their experiences. The interviews may help improve how pharmacists support patients after stroke.
VilleurbanneAges 65–100 - NCT05809180Recruiting
Tested chemo regimen for newly diagnosed older adults with DLBCL
This study tests a “mini-CHOP-like” chemotherapy plan for newly diagnosed diffuse large B-cell lymphoma (DLBCL) in people age 70 and older. It may help you learn whether this gentler regimen works well and is safe in older adults who are newly starting treatment.
Suzhou, JiangsuAges 70 years+ - NCT05814328Recruiting
Care plan after ER visit to prevent early readmissions
This study tests a “transitional care” plan for people over 75 after they leave the emergency room, aiming to reduce how soon they come back. It may help you get the right support at home and lower the risk of returning to the ER quickly.
ParisAges 75 years+ - NCT05830942Recruiting
Training walks plus brain stimulation for thinking skills in older adults
This study tests whether a structured walking exercise, combined with brain stimulation and brain scans, can improve or slow decline in thinking skills. It’s aimed at older adults who notice memory or confusion getting worse.
Gainesville, FloridaAges 65 years+ - NCT05869487Recruiting
Checking muscle loss using a leg measurement and body scan
This study compares a simple calf measurement with a body scan (X-ray–based scan) to help diagnose sarcopenia, which means age-related loss of muscle strength. It may help your care team decide on the best way to recognize muscle loss early during hospitalization and follow-up.
OrléansAges 75 years+ - NCT05902416Recruiting
Testing haplo transplant for older adults with leukemia or MDS
This study looks at using a “half-matched” stem cell transplant (haploidentical transplant) in adults around your age with acute leukemia or MDS. It may help people who cannot find a fully matched donor, but are still eligible for this type of transplant.
Beijing, Beijing MunicipalityAges 55–70 - NCT05909293Recruiting
Venetoclax maintenance for older adults with AML in remission
This study tests whether “maintenance” treatment with venetoclax can help older adults with acute myeloid leukemia (AML) stay in remission after initial therapy. It may help delay the return of AML, especially in people who achieved first complete remission.
Nanjing, JiangsuAges 60–85 - NCT05926219Recruiting
Study C-protein changes with fatigue and aging
This study looks at how a blood protein called C-protein relates to fatigue and aging, and how exercise affects it. You may be able to join if you’re otherwise healthy and willing to do muscle testing and activity monitoring.
Eugene, OregonAges 18–80 - NCT05929703Recruiting
Care approach for hospitalized older adults at risk of confusion
This trial tests new ways to help hospitalized older adults (and their family/care partners) stay comfortable and avoid or reduce episodes of acute confusion. It focuses on people who are likely to develop delirium during their hospital stay.
Orange, CaliforniaAges 70 years+ - NCT05935618Recruiting
Occupational therapy rehab for frail older adults with swallowing trouble
This trial tests an occupational therapy–based rehabilitation program to help frail older adults with swallowing problems work more safely and comfortably. You may be considered if your swallowing screen results fall in a specific range and you can participate in the therapy and consent process.
HvidovreAges 65 years+ - NCT05936515Recruiting
Training nurses and aides to shorten hospital stays
This study tests whether a new training program for nurses and nursing assistants can help elderly patients stay in the hospital for a shorter time and reduce avoidable hospital complications. You may be able to take part if you’re 75 or older and currently hospitalized on a participating hospital ward.
Bourg-en-BresseAges 75 years+ - NCT05952024RecruitingPhase 2
Acalabrutinib plus rituximab for older untreated DLBCL
This trial studies the combination of acalabrutinib and rituximab in older or frail people with newly diagnosed DLBCL (a type of lymphoma). It aims to see how well this treatment works and how safe it is for people who may not be able to tolerate standard chemotherapy.
Berkeley, CaliforniaAges 65–99 - NCT06002113Recruiting
Helping older patients share their care goals
This study helps elderly patients (80 or older) in the hospital talk about their wishes for life-sustaining treatments. It aims to make sure your care matches what matters most to you.
Barrie, OntarioAges 80 years+ - NCT06032715Recruiting
Reducing sleep medication use in older adults
This trial tests a brief program to help older adults who use sleep medications (Z-drugs) too often or for too long, and see if they can safely reduce or stop them.
LørenskogAges 60 years+ - NCT06036719Recruiting
Lung scarring study from childhood to old age
This trial looks at different types of lung scarring (called interstitial lung disease) to better understand the condition across all ages. It also includes family members of people with certain genetic mutations that affect the lungs.
Paris, Île-de-France RegionAges Any age - NCT06040489RecruitingPhase 2/Phase 3
Oral treatment for leishmaniasis in older adults
This trial tests if oral medicines can treat cutaneous (skin) or mucosal leishmaniasis in people aged 60 and older. It compares two different pills to find a safer, easier option for elderly patients.
Brasília, Federal DistrictAges 50 years+
Hear when a new Elderly trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for elderly?
- Yes. Clin2 currently lists 526 recruiting elderly studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a elderly trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a elderly trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.